Benzodiazepine Analogs as Novel Treatments for Catatonia
Award amount
$686,852Program and phase
SBIR · Phase IAward year
2011Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ORGANIX CHEMISTRY SOLUTIONS LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- HEGURQ5WJRQ9
- Solicitation number
- PA08-142
- Topic code
- NIMH
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Targeting Breast Cancer Metastasis with Id1
- Targeting Breast Cancer Metastasis with Id1
- Pharmacological Suppression of Rod Opsin as Therapy for Retinitis Pigmentosa
- Vaginal Tactile Imager for Pelvic Floor Biomechanical Assessment
- The first reversible radioligand for the hVMAT2 [3H]reserpine binding site
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Anise Health: Digital Mental Health for Asian Americans
- iKinnect2.0 for Juvenile Justice Involved Youth at Risk for Suicide Diversity Supplement
- The Development and Systematic Evaluation of an AI-Assisted Just-in-Time-Adaptive-Intervention for Improving Child Mental Health
- Scalable, non-dissociative single-cell RNA sequencing for mapping the brain in health and disease
- A MEMS-Based High-Throughput Photostimulation Device with Commercial Backplane Integration
Research funding history
15 SBIR/STTR records share this UEI (1995–2017). Reported award amounts total $6,742,699. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services